Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diffuse large B‐cell lymphoma: 2019 update on diagnosis, risk stratification, and treatment
Yang Liu, Stefan K. Barta
American Journal of Hematology (2019) Vol. 94, Iss. 5, pp. 604-616
Open Access | Times Cited: 410

Showing 1-25 of 410 citing articles:

Tumor immune contexture is a determinant of anti-CD19 CAR T cell efficacy in large B cell lymphoma
Nathalie Scholler, Régis Perbost, Frederick L. Locke, et al.
Nature Medicine (2022) Vol. 28, Iss. 9, pp. 1872-1882
Open Access | Times Cited: 128
The role of TBK1 in cancer pathogenesis and anticancer immunity
Austin P. Runde, Ryan Mack, Peter Breslin S.J., et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 79
Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma
Rong Shen, Di Fu, Lei Dong, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 45
Impact of tumor microenvironment on efficacy of anti-CD19 CAR T cell therapy or chemotherapy and transplant in large B cell lymphoma
Frederick L. Locke, Simone Filosto, Justin Chou, et al.
Nature Medicine (2024) Vol. 30, Iss. 2, pp. 507-518
Open Access | Times Cited: 44
Tumor Microenvironment Mediated Spermidine-Metal-Immunopeptide Nanocomplex for Boosting Ferroptotic Immunotherapy of Lymphoma
Tianqi Nie, Hengyu Liu, Zhengwen Fang, et al.
ACS Nano (2023) Vol. 17, Iss. 11, pp. 10925-10937
Closed Access | Times Cited: 31
B-Cell Receptor Signaling and Beyond: The Role of Igα (CD79a)/Igβ (CD79b) in Normal and Malignant B Cells
Anton Tkachenko, Kristýna Kupcová, Ondřej Havránek
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 10-10
Open Access | Times Cited: 26
Efficacy and safety of bispecific antibodies vs. immune checkpoint blockade combination therapy in cancer: a real-world comparison
Linyan Cheng, Lujun Chen, Yuan Shi, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 8
Spotlight on ideal target antigens and resistance in antibody-drug conjugates: Strategies for competitive advancement
Mingxia Jiang, Qiao Li, Binghe Xu
Drug Resistance Updates (2024) Vol. 75, pp. 101086-101086
Closed Access | Times Cited: 8
Integrating genetic subtypes with PET scan monitoring to predict outcome in diffuse large B-cell lymphoma
Matías Mendeville, Jurriaan Janssen, G. Tjitske Los-de Vries, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Integrating multi‐omics features enables non‐invasive early diagnosis and treatment response prediction of diffuse large B‐cell lymphoma
Weilong Zhang, Baoying Ye, Yang Song, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Design, Synthesis, and Biological Evaluation of Thieno[3,2-d]pyrimidine Derivatives as the First Bifunctional PI3Kδ Isoform Selective/Bromodomain and Extra-Terminal Inhibitors
Kai Ran, Jiu-Hong Huang, Yong Li, et al.
Journal of Medicinal Chemistry (2025)
Closed Access | Times Cited: 1
New Insights into Diffuse Large B-Cell Lymphoma Pathobiology
Antonio Giovanni Solimando, Tiziana Annese, Roberto Tamma, et al.
Cancers (2020) Vol. 12, Iss. 7, pp. 1869-1869
Open Access | Times Cited: 53
Immune-Checkpoint Inhibitors in B-Cell Lymphoma
Marc Armengol, Juliana C. Santos, Miranda Fernández-Serrano, et al.
Cancers (2021) Vol. 13, Iss. 2, pp. 214-214
Open Access | Times Cited: 42
Challenges in the diagnosis and management of vitreoretinal lymphoma – Clinical and basic approaches
Hiroshi Takase, Ayako Arai, Yuko Iwasaki, et al.
Progress in Retinal and Eye Research (2022) Vol. 90, pp. 101053-101053
Closed Access | Times Cited: 37
Simultaneous targeting of glycolysis and oxidative phosphorylation as a therapeutic strategy to treat diffuse large B-cell lymphoma
Richard A. Noble, Huw D. Thomas, Yan Zhao, et al.
British Journal of Cancer (2022) Vol. 127, Iss. 5, pp. 937-947
Open Access | Times Cited: 36
Optimal PET-based radiomic signature construction based on the cross-combination method for predicting the survival of patients with diffuse large B-cell lymphoma
Chong Jiang, Ang Li, Yue Teng, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 49, Iss. 8, pp. 2902-2916
Closed Access | Times Cited: 28
Curcumin in treatment of hematological cancers: Promises and challenges
Maliheh Entezari, Armita Tayari, Mahshid Deldar Abad Paskeh, et al.
Journal of Traditional and Complementary Medicine (2024) Vol. 14, Iss. 2, pp. 121-134
Open Access | Times Cited: 6
A circular RNA from APC inhibits the proliferation of diffuse large B-cell lymphoma by inactivating Wnt/β-catenin signaling via interacting with TET1 and miR-888
Yanping Hu, Yixun Zhao, Chao Shi, et al.
Aging (2019) Vol. 11, Iss. 19, pp. 8068-8084
Open Access | Times Cited: 50
MiR-144: A New Possible Therapeutic Target and Diagnostic/Prognostic Tool in Cancers
Omid Kooshkaki, Zohre Rezaei, Meysam Rahmati, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 7, pp. 2578-2578
Open Access | Times Cited: 49
Spatial signatures identify immune escape via PD-1 as a defining feature of T-cell/histiocyte-rich large B-cell lymphoma
Gabriel K. Griffin, Jason L. Weirather, Margaretha G.M. Roemer, et al.
Blood (2020) Vol. 137, Iss. 10, pp. 1353-1364
Open Access | Times Cited: 47
Identification of LINC00654-NINL Regulatory Axis in Diffuse Large B-Cell Lymphoma In Silico Analysis
Yinchu Chen, Chen Li, Nana Wang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 26
Novel roles of PIWI proteins and PIWI-interacting RNAs in human health and diseases
Zeyu Wu, Xiao Yu, Shuijun Zhang, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 15
Anomaly Detection and Artificial Intelligence Identified the Pathogenic Role of Apoptosis and RELB Proto-Oncogene, NF-kB Subunit in Diffuse Large B-Cell Lymphoma
Joaquim Carreras, Rifat Hamoudi
BioMedInformatics (2024) Vol. 4, Iss. 2, pp. 1480-1505
Open Access | Times Cited: 5
Predicting lymphoma prognosis using machine learning-based genes associated with lactylation
Miao Zhu, Xiao Qin, Xinzhen Cai, et al.
Translational Oncology (2024) Vol. 49, pp. 102102-102102
Open Access | Times Cited: 5
Diffuse Large B-cell Lymphoma Causing Central Airway Obstruction: A Case Report
Rabi Shrestha, Subekshya Khadka, Hollie Saunders, et al.
Cureus (2025)
Open Access
Page 1 - Next Page

Scroll to top